BATNA
Getting to Yes: How Deal-Making Fuels Biotech Growth – 2025 Updates
biotech dealmaking; mergers and acquisitions; licensing; venture capital; BATNA; pharmaceutical negotiations; reputation; pipeline gaps; patent cliffs; valuation; regulatory uncertainty